PT93128A - Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado - Google Patents

Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado

Info

Publication number
PT93128A
PT93128A PT93128A PT9312890A PT93128A PT 93128 A PT93128 A PT 93128A PT 93128 A PT93128 A PT 93128A PT 9312890 A PT9312890 A PT 9312890A PT 93128 A PT93128 A PT 93128A
Authority
PT
Portugal
Prior art keywords
von willebrand
preparation
willebrand factor
pasteurized
purified
Prior art date
Application number
PT93128A
Other languages
English (en)
Other versions
PT93128B (pt
Inventor
Norbert Heimburger
Klaus Wellner
Gerhardt Kumpe
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6374025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT93128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT93128A publication Critical patent/PT93128A/pt
Publication of PT93128B publication Critical patent/PT93128B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
PT93128A 1989-02-14 1990-02-13 Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado PT93128B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3904354A DE3904354A1 (de) 1989-02-14 1989-02-14 Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
PT93128A true PT93128A (pt) 1990-08-31
PT93128B PT93128B (pt) 1995-12-29

Family

ID=6374025

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93128A PT93128B (pt) 1989-02-14 1990-02-13 Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado

Country Status (12)

Country Link
US (1) US6239261B1 (pt)
EP (1) EP0383234B1 (pt)
JP (1) JP2930243B2 (pt)
KR (1) KR0149999B1 (pt)
AT (1) ATE114669T1 (pt)
AU (1) AU638969B2 (pt)
CA (1) CA2009946C (pt)
DE (2) DE3904354A1 (pt)
DK (1) DK0383234T3 (pt)
ES (1) ES2066020T3 (pt)
IE (1) IE900511L (pt)
PT (1) PT93128B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10246125A1 (de) * 2002-10-01 2004-04-15 Aventis Behring Gmbh Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
US20050226893A1 (en) * 2004-03-04 2005-10-13 Jennifer Juneau Lyophilization method to improve excipient crystallization
FR2874216B1 (fr) 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
US20070066551A1 (en) * 2004-09-07 2007-03-22 Keefe Anthony D Aptamer medicinal chemistry
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
US20090203766A1 (en) * 2007-06-01 2009-08-13 Archemix Corp. vWF aptamer formulations and methods for use
AU2009313325B2 (en) 2008-11-07 2014-05-01 Takeda Pharmaceutical Company Limited Factor VIII formulations
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN105622746A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种从冷沉淀提取凝血因子ⅷ的废料中提取人血管性血友病因子的制备工艺
CN105541997A (zh) * 2016-02-04 2016-05-04 江西博雅生物制药股份有限公司 一种高纯度和高活性血管性血友病因子的制备工艺
CN105622747A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种vWF活性保护液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4278594A (en) 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
GB2079292A (en) 1980-07-05 1982-01-20 Speywood Lab Ltd Blood Clotting Factor Production
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
GB8403473D0 (en) 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
DE3904354A1 (de) 1990-08-16
AU638969B2 (en) 1993-07-15
EP0383234B1 (de) 1994-11-30
DE59007785D1 (de) 1995-01-12
CA2009946C (en) 2000-04-11
EP0383234A2 (de) 1990-08-22
ATE114669T1 (de) 1994-12-15
DK0383234T3 (da) 1995-05-01
JP2930243B2 (ja) 1999-08-03
AU4933990A (en) 1990-08-30
ES2066020T3 (es) 1995-03-01
EP0383234A3 (de) 1991-08-07
IE900511L (en) 1990-08-14
CA2009946A1 (en) 1990-08-14
JPH02264799A (ja) 1990-10-29
PT93128B (pt) 1995-12-29
KR900012615A (ko) 1990-09-01
KR0149999B1 (ko) 1998-08-17
US6239261B1 (en) 2001-05-29

Similar Documents

Publication Publication Date Title
PT93128A (pt) Processo para a preparacao de um concentrado de factor de von willebrand purificado e pasteurizado
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
PT99779A (pt) Processo para a preparacao de composicoes liquidas concentradas a base de sucralose
DE3577802D1 (de) Verfahren zur aktivierung von viren in immunoglobulin.
DE3675687D1 (de) Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine.
DE3677520D1 (de) Vorrichtung zur behandlung von behaeltern.
BR8603413A (pt) Sistema de controle de maquina e processo para operar maquina
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
DE3676215D1 (de) Verfahren zur herstellung von 2,3,4,5-tetrafluorbenzoesaeure.
DE3774897D1 (de) Behandelte sojabohnen mit reduziertem phosphor- und kaliumgehalt, verfahren zur zubereitung derselben und damit erhaltene sojabohnen-nahrungsmittel.
BR9301641A (pt) Processo para produzir uma preparacao de fator viii,altamente purificada e uso
DE3784140D1 (de) Methode zur behandlung von polyamidfasermaterialien mit salzen sulfonierter novolake mit zweiwertigen metallen.
BR8304356A (pt) Concentrado em suspensao para controle de erva daninha e processo para controle de erva daninha
DE3783199D1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
DE3787543D1 (de) Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen.
DE3673049D1 (de) Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon.
PT88254A (pt) Processo para a preparacao de derivados de eritromicina a modificada em c.12
ATE109950T1 (de) Verwendung von geschützten aminosäuren in futtermitteln für schafe.
DE3671246D1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
DE59310073D1 (de) Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
BR9103660A (pt) Processo para o aperfeicoamento de resistencia a corrosao de componentes nitrocarburados de materiais ferrosos
FI860377A7 (fi) Menetelmä muovisten ruokapurkkien lämpökäsittelemiseksi.
DE68906560D1 (de) Verfahren zum herstellen von integral mit schaufeln versehenen laeufern.
IT1152195B (it) Soluzioni concentrate di coloranti 1,4-dialchil-arilammino antrachinoni per la colorazione di prodotti petroliferi
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950908

PC3A Transfer or assignment

Free format text: 980126 CENTEON PHARMA GMBH DE

PD3A Change of proprietorship

Owner name: AVENTIS BEHRING GMBH

Effective date: 20000316

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050308